News

Allogene Therapeutics to Showcase Innovations at Investor Events

Allogene Therapeutics to Showcase Innovations at Investor Events

Allogene Therapeutics Announces Participation in Investor Conferences

Allogene Therapeutics, Inc. (NASDAQ: ALLO), a leading clinical-stage biotechnology company, is gearing up to participate in two prominent investor conferences in the near future. Known for its pioneering work in allogeneic CAR T (AlloCAR T™) therapies for cancer and autoimmune diseases, Allogene is set to make a significant impact at these events.

Upcoming Investor Conferences

Mark your calendars for the following conferences where Allogene Therapeutics will be presenting:

Stifel 2024 Healthcare Conference

This conference is scheduled for a Monday morning engagement. Allogene will present on November 18, 2024, starting at 5:35 AM PT or 8:35 AM ET, showcasing its latest developments in cell therapy.

Jefferies London Healthcare Conference

Just days later, Allogene will also be featured at the Jefferies London Healthcare Conference on November 20, 2024, at 10:00 AM GMT or 5:00 AM ET. Attending this conference allows for direct insights into their innovative approach to healthcare.

Webcast Availability

For those interested in accessing these presentations, Allogene will provide any available webcasts on their official website. Visit www.allogene.com under the Investors tab in the News and Events section. After the live events, recordings will be made available for approximately 30 days, ensuring that investors have the opportunity to stay updated.

About Allogene Therapeutics

Headquartered in South San Francisco, Allogene Therapeutics is at the forefront of cell therapy innovations. The company focuses on developing allogeneic chimeric antigen receptor T cell products designed for broader accessibility and efficiency. Their team, boasting extensive experience in cell therapy, is dedicated to delivering these therapies to patients on-demand and at a scale that meets growing needs.

Company Mission and Goals

Allogene's mission revolves around effectively providing readily available treatments through enhanced cell therapy solutions. Their pipeline of 'off-the-shelf' CAR T candidates aims to revolutionize how cancer and autoimmune conditions are managed. This commitment to innovation is what sets Allogene apart as they prepare for future challenges in the biotechnology field.

Contacting Allogene Therapeutics

Interested parties can connect with Allogene for further inquiries. The Media/Investor Contact is Christine Cassiano, the Executive Vice President, and Chief Corporate Affairs & Brand Strategy Officer. Christine can be reached via email at Christine.Cassiano@allogene.com.

Frequently Asked Questions

What is Allogene Therapeutics known for?

Allogene Therapeutics specializes in developing allogeneic CAR T products for treating cancer and autoimmune diseases.

When will Allogene present at the investor conferences?

Allogene will present at the Stifel Healthcare Conference on November 18, 2024, and at the Jefferies London Healthcare Conference on November 20, 2024.

How can I watch the presentations from the conferences?

Webcasts of the presentations will be available on Allogene's website under the Investors tab, and replays will be accessible for about 30 days after the events.

What is the goal of Allogene Therapeutics?

The goal of Allogene is to make cell therapies accessible and efficient, providing patients with effective treatment options on-demand.

Who can I contact for more information about Allogene?

For information, you can contact Christine Cassiano at Allogene via the email address provided.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Buffett Steps Down, New Faces at Berkshire Hathaway

Updated Category News Views 3

End of an Era: Warren Buffett's Retirement Warren Buffett—there's a name that's echoed through the halls of investment for decades. Today, he's pulling down the curtain as Chairman of Berkshire Hathaway (NYSE: BRK). No fanfare, just a nod to the inevitable with his classic, humor-tinged confession: 'Father Time always wins.' Can’t argue with the man who’s seen the...

Continue Reading
Debbie's Dream Foundation Launches 2026 Youth Art Contest

Updated Category News Views 4

Young Artists Called to Inspire a Cancer-Free World What's the first image that pops into your head when you think of a world free from cancer? That's the magic question on deck for this year's Youth Art Contest by Debbie's Dream Foundation. Imaginations are set to run wild as the competition opens its gates to artists under 18, calling for visions splashed across...

Continue Reading
IRS Views Challenge Tax-Engineered Healthcare Schemes

Updated Category News Views 3

Nonprofit Models Shine Amid IRS Scrutiny Out in Oxnard, California, there's a brewing storm in the healthcare sector. No, it's not a billing error or yet another scandal. We're talking about a seismic shift that could poke holes in those tax-engineered Section 105(b) programs, all thanks to some hard-hitting IRS memoranda. The Nonprofit–TPA Model: A Safer Bet? Enter...

Continue Reading
Digital Wine Atlas Maps 4.3 Million Vineyards Globally

Updated Category News Views 4

Revolutionizing Viticulture with Data In today's wild world, climate change isn't just shifting weather patterns—it's upending the age-old map of wine-making regions. We've got a new player on the field: the World Winery Map. It's digital, massive, and it’s shaking things up for winemakers and grape enthusiasts alike. This platform covers a staggering 4.3 million...

Continue Reading
Vetology Reinvents AI Models for Veterinary Radiology

Updated Category News Views 3

Revamping AI in Veterinary Practices Out there in San Diego, Vetology's been rolling up its sleeves and getting down to brass tacks with a complete do-over of their AI classifiers. They’ve rebuilt all 94 of them, every last one, on a brand-new architecture. No small task, this overhaul stretched from June to August and it wasn't just paint and polish but a whole new...

Continue Reading
AI Ambassadors Rethink Arbitration's Future

Updated Category News Views 5

Navigating the AI Terrain in Arbitration It's 2026 and artificial intelligence isn't just a buzzword anymore; it's reshaping every corner of how disputes get resolved. The American Arbitration Association (AAA) has jumped into the mix, launching an AI Ambassador program to tackle a wave of AI-induced challenges. These aren't just academic exercises—this is a hard-nosed...

Continue Reading
Bellissima Bags Allure Award for Curly Hair Tool

Updated Category News Views 4

Award-Winning Tool Headlines 2026 Beauty Scene There's a shake-up in the world of hair tools, folks. Bellissima's Diffon Supreme has snagged a 2026 Allure Best of Beauty Award for its prowess in taming the curly, wavy, and coily strands we all crave to manage. Performance Meets Innovation in Bellissima's Latest Let's not beat around the bush. The Diffon Supreme's trump...

Continue Reading
Menopause Policy Advocacy Takes Center Stage in DC

Updated Category News Views 4

Unlikely Spotlight on Menopause at Capitol Hill If you told me a couple of years back that menopause would become a front-page political issue, I would've laughed. Yet, here we are, with over 125 advocates from 29 states converging on Washington, D.C., demanding legislative action on menopause. Why Menopause Matters in Policy The fact that more than half the population is...

Continue Reading
ETERC's Ele Aims to Revolutionize STEM Education for All

Updated Category News Views 5

The AI Mentor Battleground in Education Ever found yourself wondering how public schools could step up their game without dumping money down the tech rabbit hole? ETERC’s latest push with Ele may just be a game-changer for them. We're not talking about your run-of-the-mill chatbot regurgitating facts from the internet—this is an AI tricked out for personalized...

Continue Reading
DAHON's Tech: Crafting Folders That Ride Like Road Bikes

Updated Category News Views 3

The Folding Bike Revolution: More Than Just a Fad You've seen them zipping around—those compact, folding bikes. They're not just for urban commuters looking to save space. Oh no, this is a full-blown cycling revolution we're talking about. DAHON, a name that's been rolling since 1982, has been riding these waves and making strides that others can only dream of. While...

Continue Reading

Top 5 Most Recently Viewed Articles

X-Golf Wexford Reopens: $1,200 Contest & Upgrades

Updated Category News Views 8

X-Golf Wexford: Teeing Off Again Under New Ownership There's nothing like a little competition to spice up a reopening. X-Golf Wexford, located in the heart of Wexford, PA, is rolling out the green carpet for its grand reopening this Saturday, August 22. Now under new ownership, the joint is throwing a free public shindig where golf meets gaming with a mix of contests and...

Continue Reading
Jack Henry Celebrates TIME's Best Company Honors Again

Updated Category News Views 6

Jack Henry Shines in TIME's Elite Listing Ah, how sweet it is for Jack Henry (NASDAQ: JKHY), basking in the glow of grace as they snag a spot on TIME's coveted list of America's Best Companies for the third year in a row. Now that's a hat trick worth talking about! In a world where ratings and ranks can feel like a minefield, this is a signal worth paying attention to....

Continue Reading
Manchester United Reports Declining Fourth Quarter Earnings

Updated Category News Views 128

Manchester United Reports Its Fourth Quarter Results Manchester United PLC (NYSE: MANU) has recently released its fiscal fourth-quarter results for 2024. The numbers show a significant year-on-year sales drop of 15.0%, totaling 142.2 million British pounds, or about $179.43 million. Unfortunately, this result didn't meet analysts' expectations, which had projected sales...

Continue Reading
Celebrating a Decade of Innovation at Scality Day 2025

Updated Category News Views 134

Scality Day 2025: A Milestone Celebration As we step into an era where artificial intelligence (AI) and cyber resilience are crucial, Scality is excited to celebrate the remarkable 10th anniversary of Scality Day on October 16, 2025. This prestigious event is set to take place in Paris, gathering minds from diverse sectors to share insights on the transformative power of...

Continue Reading
Frontline plc Announces Q2 2024 Presentation Details

Updated Category News Views 105

Frontline plc's Second Quarter 2024 Presentation Frontline plc is set to announce its results for the second quarter of 2024. This eagerly awaited presentation will be held via webcast and conference call, providing investors and stakeholders with essential insights into the company's recent performance. Key Information About the Presentation The upcoming presentation...

Continue Reading